BioSpace Movers & Shakers, March 4
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Stay updated with breaking news from Singular Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
OMIC earnings call for the period ending December 31, 2021.
The second year of the COVID-19 pandemic saw a wave of global demand for coronavirus tests that finally reached the public markets. Diagnostics companies raised hundreds of millions of, and in some cases over a billion, dollars by pitching Wall Street on their ability to meet that need.
The startup has developed wet lab and artificial intelligence tech to screen small molecules in a less expensive way, giving researchers better odds of uncovering new medicines.
In this timely episode of GEN Live, we’ll discuss all of these topics with genomics veteran and expert in this space—Shawn Baker, PhD. Baker is a genomics startup advisor and consultant. He was one of the first people to join Illumina and has been involved in the genomics space since—for the past 20 years.